Catalent
CTLT
#1737
Rank
C$15.91 B
Marketcap
C$87.70
Share price
0.00%
Change (1 day)
12.11%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Cash on Hand

Cash on Hand as of September 2024 : C$0.46 Billion

According to Catalent's latest financial reports the company has C$0.46 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Catalent - Cash on Hand chart (from 2013 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-06-30C$0.37 B-46.49%
2022-06-30C$0.69 B-42.2%
2021-06-30C$1.19 B-7.36%
2020-06-30C$1.29 B186.11%
2019-06-30C$0.45 B-16.18%
2018-06-30C$0.53 B35.29%
2017-06-30C$0.39 B121.98%
2016-06-30C$0.17 B-4.86%
2015-06-30C$0.18 B137.78%
2014-06-30C$79.39 M-29.03%
2013-06-30C$0.11 B-20.96%
2012-06-30C$0.14 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Supernus Pharmaceuticals
SUPN
C$0.38 B-16.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
C$0.23 B-48.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
C$2.82 B 510.77%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
C$0.44 B-3.67%๐Ÿ‡บ๐Ÿ‡ธ USA